Je tiens à exprimer tout mon soutien au projet RISE, porté par la Fondation AHADI. Cette initiative ambitieuse, visant à autonomiser 1 000 femmes en situation de handicap en tant que leaders d’ici 2030, constitue une démarche essentielle pour renforcer l’inclusion, l’égalité des chances et la représentation des femmes dans toutes les sphères de décision.

Les résultats obtenus lors des projets pilotes en France et en Afrique démontrent la pertinence et l’impact concret de cette approche. Étendre aujourd’hui ce programme à l’échelle internationale est non seulement inspirant, mais également indispensable pour favoriser un leadership véritablement inclusif et une transformation culturelle durable.

Je salue la vision, l’engagement et la détermination qui animent ce projet. RISE incarne parfaitement les valeurs de résilience, de solidarité et d’autonomisation, et contribue à construire un monde plus juste et plus accessible pour toutes et tous.
Bravo Deza

السلامُ عليك أيها النبي، نذكرُك ونحبك زيادةً كلما رأينا ثمار غرسك في أمتك؛ مجاهدين وصابرين ومقاومين ومؤمنين وشهداء أعزاء بالدين لا تكسرهم الشدة ولا يُرهبهم تكالب أعدائهم عليهم. شكرًا مرسال لدعم فلسطين! 

Safe travels Joshua! You are an Inspiration!! Praying for some great runs and a safe journey to all who are running to Knoxville. GO VOLS! 

सर्वे भवन्तु सुखिनः, सर्वे सन्तु निरामयाः ।
सर्वे भद्राणि पश्यन्तु, मा कश्चिद् दुःखभाग् भवेत् ॥

If Ryan Tilghman can run his next set under 8:45/mile, I’ll donate another 100. 

Hearing about this on Sam Harris's Podcast Making Sense made it clear that I should be donating too.

Good nutrition helps you avoid many health issues. An ounce of prevention works.

We support women with disabilities to lead boldly, break barriers, and shape a more inclusive world — in line with the 2030 SDGs



**AHADI Foundation – Empowering Women with Disabilities Through Leadership**

Founded in 2023 by Deza Nguembock—a disabled woman, social entrepreneur, and changemaker originally from Cameroon and now based in France—the AHADI Foundation is committed to transforming the leadership landscape for women with disabilities around the world.

Born from Deza’s lived experience of facing ableism, racism, and sexism, AHADI envisions a world where women with disabilities are seen, heard, and empowered to lead. Our mission: to break the cycle of invisibility by equipping 1,000 women with disabilities to rise as leaders and to build a global network of 20,000 emerging changemakers by 2030, in alignment with the UN Sustainable Development Goals.

💬 Why Your Support Matters

AHADI is not just a foundation—it’s a **movement** reshaping inclusion through leadership and visibility for women with disabilities around the world. An area that is still largely underfunded. Too often, organizations focus solely on inclusion without progressing to leadership, which is a crucial step for the empowerment of women with disabilities. We are now launching our **first fundraising campaign**, **your support is essential**.

💛 Every donation helps us fund:

- AHADI Leadership 
- AHADI Community 
- AHADI Data & Research
- AHADI Art for Change

You're not just giving—you’re **investing in a future** where every woman with a disability can lead with pride, power, and purpose.

🔍 Why This Matters

Women with disabilities face *systemic, compounded barriers* every day:

- **2 to 3 times** more likely to experience violence than non-disabled women
- **3 times** more likely to be illiterate than non-disabled men
- **2 times** more likely to be unemployed
- Almost invisible in decision-making roles—only **2.3%** held positions as legislators, senior executives, or managers in 19 countries (UN Women, 2017)

They are *routinely excluded* from economic and political life due to overlapping gender and disability discrimination. At AHADI, we are actively changing this—through leadership training, advocacy, visibility campaigns, and a strong, global sisterhood.

🎯 Our Key Programs

**💼 Leadership Program**
A 10-month hybrid initiative combining 4 months of intensive training with 6 months of personalized coaching. It empowers established women leaders with disabilities to lead advocacy efforts, claim media space, and mentor the next generation.

**🤝 Community Program**
Guides women at the start of their leadership journey by offering personal development tools, well-being sessions, and inspiring encounters—co-facilitated by alumnae of the Leadership Program.

**🎨 AHADI Arts & Culture**
Through immersive art installations and exhibitions, we challenge stereotypes and amplify the voices and visibility of women with disabilities.

**📊 AHADI Data & Research**
We collect and share key data to inform public policies and measure impact. Our upcoming **2030 Observatory** will track government commitments to four key articles of the UN Convention on the Rights of Persons with Disabilities.

✨ Key achievements

- **March 2024**: Launched our first pan-European study on the visibility of people with disabilities in social, professional, media, and political spheres.
- **2024–2025**: Our **leadership pilot program** launched in France and expanded to Africa. To date, **77 remarkable women from 15 countries** have joined the movement.
- **March 2025**: Launched **"Les Objets"**, our first global awareness campaign—aired *in prime time* on CNN in North America and EMEA. Coming soon on France Télévisions and in **500+ cinemas** across France.
- **2025 (in progress)**: Our first art installation, *Aparté. Confidences. Liberté*, explores the intersection of perception, desire, and societal imagination surrounding disabled women.

AHADI Foundation

High quality medical services for marginalized groups in Cairo and the region.

Mersal Foundation for Charity and Development is a non-profit organization that serves in the health field and works on providing all types of healthcare with high quality to whoever is in need.

**Vision**
To be the number one medical organization in Egypt and the Arab region and proactive in ensuring the right in healthcare for the marginalized groups and those who are in need the most.

**Message**
Working on analyzing and filling the gaps of the healthcare system to provide high quality medical services on the basis of equality and dignity through enabling a charitable healthcare system for whoever cannot afford it, as well as contributing to the development of the health sector.

**Objectives**  

- Providing medical services to whoever deserves them regardless the cost or for how long they will be needed.
- Spreading medical awareness in all the places it serves in.
- Achieving sustainability in funding its activities Core Values.
- Privacy: Mersal ensures the patient's eligibility to receive its services without hurting their dignity or exposing them to any kind of embarrassment.
- Healthcare With No Discrimination: Mersal is an open arm to all patients with no discrimination whatsover; whatever religion, nationality, color, or language, all patients in need are welcomed to receive the organization services.
- High Quality: Mersal provides all types of medical services in the highest possible quality through its network of specialized medical personnel.
- Credibility and Transparency: Mersal announces the size and sources of its fund as well as its administrative and medical expenditures, The foundation financial reports and annual budgets are available through several outlets through which any person can explore how resources are managed. Mersal believes in the importance of being specialized in specific fields and its early choice was the healthcare services.

In the past six years, the organization registered over 25,000 patients from 27 provinces.  Mersal has been seeking to enable access to its services all over the country. And the dream of helping those who are in need whoever they are and whatever the cost and time is still alive, Mersal has worked over the past six years on getting close to its patients throughout their treatment journey.

Mersal Foundation for Charity and Development 

The Fungi Foundation is a global organization that works for the Fungi, their habitats, and the people who depend on them.

Launched in 2012, the Fungi Foundation is the first NGO dedicated to the fungi kingdom. Since its inception, it has achieved numerous milestones while dedicating itself to exploring the fungi world in view of increasing knowledge of their diversity, educating about their applications, and recommending public policy for their conservation. As part of our ongoing 3F initiative, the foundation played a key role in enabling Chile to become the first country in the world to include protection of fungi in its environmental legislation. More recently, the foundation proudly announced the Fantastic Fungi Education Curriculum, the world's first mycological set of courses designed for schools.

In short, the Fungi Foundation envisions a healthy planet in which Fungi are recognized, protected, and embraced as the interconnectors of nature; a mission that would be impossible without the essential support of our kind, engaged donors.

Fungi Foundation

Extending and improving the lives of people with ALK+ lung cancer by raising funds for research and patient support programs.

**Our Vision**

We envision a world where ALK+ lung cancer is a chronic or even curable condition and the next person diagnosed with lung cancer does not have to live under the current stigma.

**Our Start**

\#SweatForBreath started as a grassroots fundraising campaign during Lung Cancer Awareness Month in 2023. After being diagnosed with Stage IV ALK+ lung cancer in November 2022, David Cornbrooks became keenly aware that he was benefiting from the selfless fundraising and awareness efforts of the patients before him.

[Listen to David's story here.](https://www.youtube.com/watch?v=lWcS-yN7Qxw)

The \#SweatForBreath campaign in 2023 became David, and his wife, Lisa’s, way to help the next generation ALK+ lung cancer patients.

\#SweatForBreath accelerated beyond more than just a typical fundraiser.  The initiative quickly evolved into a community of patients, caregivers, family, and friends seeking to make David and Lisa's vision a reality and the road to that vision more tolerable. People donated, sweat at the in-person cycle event, posted on social media, and helped fundraise through organizing group walks, selling art, "gifting" donations on behalf of clients, and much more.

Their success in 2023 compelled David and Lisa to officially transition the \#SweatForBreath campaign into the Sweat For Breath Foundation, operating through a fiscal sponsorship with Players Philanthropy Fund, a Maryland charitable trust recognized by IRS as a tax-exempt public charity under Section 501(c)(3) of the Internal Revenue Code (Federal Tax ID: 27-6601178).

**Our Impact**

Since 2023, over **1,450 donors** have given nearly **$400,000** to the Foundation (or its predecessor campaign). 100% of the proceeds have gone directly to The Johns Hopkins Sidney Kimmel Center in Baltimore, MD to support Dr. Vincent Lam’s ALK+ lung cancer research.

This support provided the critical funding needed to launch Dr. Lam’s clinic trial, which will evaluate the safety of a cancer peptide vaccine to prevent or delay acquired resistance in advanced ALK+ lung cancer patients currently on ALK targeted therapy. Dr. Lam’s vaccine is the **first ALK+ vaccine in the world** to be tested in a clinical trial. Dr. Lam administered the vaccine to the first patient **in clinic on May 13, 2024**!

-----------

*The Sweat for Breath Foundation is a project of Players Philanthropy Fund, Inc. a Texas nonprofit corporation recognized by IRS as a tax-exempt public charity under Section 501(c)(3) of the Internal Revenue Code (Federal Tax ID: 27-6601178,[ppf.org/pp](https://ppf.org/pp)). Contributions to The Sweat for Breath Foundation qualify as tax-deductible to the fullest extent of the law.*


The Sweat For Breath Foundation

Cuddles Foundation nourishes children in their fight against cancer. Because #Foodheals



**Feed Children. Starve Cancer.**

Every year, approximately 76,000 children in India may develop cancer, with 58% of them being severely malnourished at the time of diagnosis. For these children, nutrition can mean the difference between life and death. Every child deserves a chance at a cure, and we are here to make that happen.

At Cuddles Foundation, we partner with over 40 government and charity cancer hospitals to support children through our FoodHeals program. Our mission is to ensure that children undergoing cancer therapy receive comprehensive nutritional support. This includes access to trained clinical pediatric nutritionists, expert dietary counsel, supplements, hot meals, monthly ration baskets, and caregiver support. Good food helps the medicine work!

This multi-pronged approach tackles a simple but often ignored aspect of a child’s successful recovery from cancer. While undergoing treatment, it is essential that children have freshly prepared, nutritious food in sufficient quantity and don't stay hungry for long periods. The impact of our work is evident. When part of the FoodHeals Program, 82%* of patients improved or maintained their nutritional status, despite cancer therapy like chemotherapy or radiation.

Additionally, 96% of children followed up* on their treatment plan when nutrition was a part of it, demonstrating the program’s effectiveness. Besides the love and affection of our patients, their families, and our supporters, we’ve won some prestigious awards along the way. This includes the National Award for Child Welfare (2015-16), the Akshaya Patra and UN Global Compact Award (2018) and most recently we received the Global CSR & ESG Awards 2024 - Top 10 Best NGOs of the Year (2024).

Join us in our mission to nourish hope and fight childhood cancer. Your support can make a world of difference.

**As per Cuddles annual impact statistics 2023-24*
**Follow-up treatment rate: Patients who returned for a second visit or continued treatment when nutrition was a part of it.*

Cuddles Foundation

Zig is a general-purpose programming language and toolchain for maintaining robust, optimal, and reusable software.

The Zig Software Foundation is a non-profit corporation founded in 2020 by Andrew Kelley, the creator of Zig, with the goal of supporting the development of the language. Currently, the ZSF is able to offer paid work at competitive rates to a small number of core contributors. We hope to be able to extend this offer to more core contributors in the future.

Zig Software Foundation Inc

We match donations to any charity you choose while introducing you to super-effective charities. Learn more: GivingMultiplier.org

[**Giving Multiplier**](https://givingmultiplier.org) is a research project created at Harvard University that adds matching funds to any charity of your choice while introducing donors to highly effective charities recommended by experts.

*Resources:*

- [Make a donation that gets matched](https://givingmultiplier.org)
- [Become a matching funder](http://givingmultiplier.org/matching) (Donations made on this page will also go toward our matching system.)
- [Sign up to our newsletter](http://eepurl.com/i0GHhc)
- [Learn about our philosophy](https://givingmultiplier.org/philosophy)

Questions? Email us: **info@givingmultiplier.org**

Giving Multiplier

Dedicated to inspiring and preparing youth for successful, thoughtful, and ethical engagement in STEAM and related professions.

To inspire lifelong engagement and ethical leadership in science, technology, engineering, arts, mathematics, and related professions through its proven educational model for mentoring, challenging, and motivating students. By building communities among students, teachers, and professionals, NYSAcademy programs complement, broaden, and enhance the traditional school curriculum leading to careers in science, technology, engineering, arts, mathematics, and related professions.

National Youth Science Academy

Developing the roadmap for a sustainable, secure, and just global protein supply 🧫🌱


Check out what your support makes possible at gfi.org/your-impact. 

The Good Food Institute (GFI) is a global network of nonprofit organizations developing the roadmap for a sustainable, secure, and just protein supply. Industry alone will not meet this challenge at the scale or speed we need. GFI is accelerating the transformation of the food system by identifying solutions and mobilizing resources to make alternative proteins the default way meat is made.

GFI is a network of nonprofits around the world strategically based in the most critical economies for alternative protein advancement. In Asia, Europe, Brazil, India, Israel, and the U.S., GFI’s teams are mobilizing the international community to use markets and technology to replace harmful practices with ones that are better for the climate and biodiversity, for food security, and for global health.

GFI’s Focus
As a nonprofit, GFI is uniquely positioned to accelerate the transition to alternative proteins by focusing on three programmatic priorities:

-Cultivating a strong scientific ecosystem | GFI’s science and technology teams map out the most neglected areas that will allow alternative proteins to compete on taste and price. GFI meets these challenges by developing open-access research and resources, educating and connecting the next generation of scientists and entrepreneurs, and funding research that benefits alternative protein development across the sector. 

-Influencing policy and securing government funding | GFI’s policy teams ensure that alternative proteins are a part of the policy discussion around climate change mitigation and global health. In every region where GFI has a presence, teams advocate for government funding and incentives to transition to alternative proteins and are paving the way for the approval of novel proteins such as cultivated meat.

-Ensuring industry prioritizes alternative proteins | GFI’s corporate teams are creating a transformation of our global meat supply. GFI works to replicate past market transformations by showing companies of all sizes, from startups to multinational corporations, how alternatives to animal products can be profitable while meeting environmental, social, and governance goals.

Reimagining meat
The very real threats of climate change, global food insecurity, antibiotic resistance, and pandemics require us to imagine a different future of food. Alternative proteins are the solution that will securely and sustainably feed the world.

GFI’s global community of scientists, policy experts, and corporate specialists are creating a world where alternative proteins are no longer alternative.



The Good Food Institute

Supporting research on the welfare of neglected animals.

There are millions of known arthropod species. There are doubtless millions more. And there may be quintillions of individual arthropods.

We know little about most of these animals and, as a result, little about how their welfare might be improved in contexts where humans use, manage, or otherwise affect them.

The mission of the Arthropoda Foundation is to support research on the welfare of arthropods. We value both basic and applied projects. We are particularly interested in research with a clear path to impact, whether by shaping future science or informing real-world decision-making.

Arthropoda Foundation

We are a research hospital that treats patients in all medical disciplines, focusing on oncology, neurology, and diagnosis.

The Fondazione Casa Sollievo della Sofferenza – Opera di San Pio da Pietrelcina (transl. Home for the Relief of Suffering Foundation – Work of Saint Pio of Pietrelcina) is a not-for-profit research hospital located in the city of San Giovanni Rotondo (FG), in the Puglia Region, Southern Italy.
As per Canon 1303 §1 of the Code of Canon Law, it has public, canonical and civil legal personality; it is therefore subject to the supervision of the Holy See and, on its behalf, of the pro-tempore Cardinal Secretary of State. 
Many of the stages that have thus far marked the history of the Work of San Pio of Pietrelcina have been achieved thanks to the loving generosity of many benefactors who, sharing the mission indicated by San Pio da Pietrelcina, the relief of suffering, wanted to donate to his work.

HISTORY
The hospital was founded and inaugurated by Saint Pio of Pietrelcina on May 5, 1956 with a capacity of 250 beds. It took on the status of Provincial Hospital on 4 August 1971 and then of Regional General Hospital on 2 June 1980, thus becoming part of the Italian National Healthcare System. Since 16 July 1991, with a Decree of the Minister of Health and the Minister of University and Scientific Research, it has been a Research Hospital. Originally, the object of its scientific activity was limited to genetic and hereditary-familial diseases; subsequently, the Minister of Health, by the 5 December 2012 Decree, extended the research areas of its competence to "Genetic diseases, innovative therapies and regenerative medicine". Recently, on the occasion of the presentation of the research lines for the three-year programme of the Italian Research Hospitals 2022-2024, Casa Sollievo identified “Diagnostic acitivity, Neurology and Oncology” as its main research thematic areas, thus becoming a polythematic Research Hospital.

MISSION
The Foundation's mission is to provide health care and carry out research activities. In addition, the Foundation offers training activities for its personnel.
Around 2,750 people work at the Foundation.
The Foundation (hereinafter “CSS”) consists of three structures based in San Giovanni Rotondo: the hospital Casa Sollievo, the polyclinic Giovanni Paolo II, where outpatient activities are carried out, and the ISBReMIT research center for regenerative medicine (Institute for Stem-cell Biology, Regenerative Medicine and Innovative Therapies); and the Mendel Institute in Rome, where research and diagnostic activities are carried out. In San Giovanni Rotondo, it also owns and runs a retirement home for the elderly.
In addition, CSS owns 3 hospitality facilities where affordable accommodation is offered to hospitalized patients’ relatives who have to assist them; and another facility (Casa Zeni) where accommodation is offered free of charge to the parents of the little patients hospitalized in the oncology-hematology unit.
Moreover, the Foundation includes the Padre Pio Prayer Groups Centre, which was also founded by San Pio and coordinates the Padre Pio prayers groups throughout the world, according to the Founder’s wish that Prayers Groups live and testify the importance of prayer and pray for CSS.
Lastly, CSS publishes a monthly periodical and posts on the Foundation’s official channels on the web updates on its research and clinical activity and its spiritual activity and the teachings of the Founder.
The hospital offers assistance also to people from underdeveloped countries. 
Moreover, a free-of-charge shuttle service has been provided for many years to radiotherapy patients coming from Bari and surrounding cities (Southern Puglia).

THE CLINICAL ACTIVITY
CSS has around 756 beds, 38 medical and surgical inpatient units, 26 operating rooms, in addition to services, diagnostic and multi-specialist outpatient units.
In 2022, the hospital recorded over 30,000 hospitalizations and 870,000 outpatient performances. 
Regarding the advanced technological equipment, CSS has 1 "Da Vinci" surgical robot, 1 PET/CT device, 3 linear accelerators, 4 CT devices, 1 CT simulator for radiotherapy, 4 NMR equipment, 3 digital angiographs, 2 gamma cameras and a RIS/PACS system for the filmless management of the radiology department.
Furthermore, CSS hosts an Umbilical Cord Bank and a Human Milk Bank.
Recent Achievements
In addition to the many important activities carried out in CSS, 3 new units have been opened: 1. a new Emergency Room hosting an Observation and Assessment Ward; 2. an Hematopoietic Stem Cell Transplant Center. 3. an Sub-Intensive Geriatric Unit. 
CSS has also established a Stroke Unit, a Lung Unit, a Breast Unit, a Head and Neck Unit, and a Molecular Tumor Board to guarantee appropriate, quality and homogeneous procedures.
Future goals
Important technological investments have been planned for the years 2023-2025 in the following areas: oncology/nuclear medicine, diagnostic imaging, ICU, and surgery. 

THE RESEARCH ACTIVITY
The research activity is conducted in the Polyclinic, the ISBReMIT research center and at the Mendel Institute, for a total of 17 research groups.
Recent achievements
The consolidated experience of the staff working in CSS in the study of genetic diseases since 1991 and the continuous updating of technologies, instrumentation and genomics and post-genomics skills have made it possible to direct the research and clinical-assistance activity towards two complementary research lines: "personalized medicine - system biomedicine" and "regenerative medicine" based on the study of tumor stem cells and the use of normal stem cells.
The scientific fields in which the Institute is mostly involved in "personalized medicine" concern the identification of the genetic causes of rare diseases and the identification of diagnostic, prognostic and predictive markers in complex pathologies, including tumor pathologies. Regarding the identification of the genetic causes of rare diseases, we use the new next generation sequencing (NGS) technologies and the skills acquired by the bioinformatics unit, one of the first established at national level. In parallel, the Institute boasts a large collection of induced pluripotent stem cells (iPSCs), produced from patient fibroblasts, in which pathogenetic variants have been identified, and use the skills acquired in differentiating them into mature cells, in particular astrocytes, neurons and oligodendrocytes.
Regarding regenerative medicine, two important studies were conducted and concluded: a phase I trial on anti-Multiple Sclerosis therapy based on the use of human neural stem cells, approved by the Ministry of Health and the Italian Medicines Authority AIFA (EudraCT code 2015-004855-37); and a phase I/II trial on anti-glioma therapy with biological drugs (EudraCT code: 2016-001761-92). The results of these studies will published in prestigious international journals.
In 2015, the new ISBReMIT Regenerative Medicine Research Center was started. It is a cutting-edge structure in terms of conception and equipment in the field of translational medicine for genetic, degenerative and oncological diseases. The structure hosts, together with the highly technologically equipped laboratories, a cell factory and a laboratory for the production of biopharmaceuticals under Good Manufacturing Practice, i.e. for clinical use, including somatic stem cells and iPS, vectors for gene therapy and biomaterials.
It should be noted that CSS has recently become part of three Networks of the Italian Research Centers: since 2016 it has been an Ordinary Associate of Alleanza Contro il Cancro; since December 2018, of the National Research Network on Aging; and, finally, since March 2020 of the Neuroscience Network. Starting from 2022, CSS has been part of the European reference networks for rare and uncommon diseases (European Reference Networks - ERN), in particular ERN-SKIN on diseases of dermatological interest, and ERN ReCONNET on musculoskeletal diseases and pathologies of the connective tissue.
Researchers publish about 200 scientific articles in the most renowned journals (Science, New England Journal of Medicine, Nature Genetics) every year. They are engaged both as Principal Investigators and as partners in research projects in the biomedical field and ICT, obtaining funds from the EU (H2020 and FP7) and national or regional calls.
CSS is also a partner in Research and Innovation projects funded by private and public bodies, e.g. from the EU both under Horizon 2020 and Horizon Europe, in the field of digital transformation of healthcare. The main areas of involvement concern Assistive Robotics, Artificial Intelligence, Big Data generated by consumer devices, eHealth, Digital Therapies, the Internet of Things and Cybersecurity.
Future goals
Starting from the identification of the genetic causes of diseases, the goal is to develop advanced therapies to bring to the patient's bedside and tailored to him/her.
Furthermore, at the end of 2023, the phase II study "Neural Stem Cell Treatment for Amyotrophic Lateral Sclerosis: A multicenter, randomized placebo controlled and biological endpoints clinical Trial" (EudraCt 2018-002373-22) will be launched. This involves the use of neural stem cells on patients suffering from Amyotrophic Lateral Sclerosis.

CONCLUSION
Casa Sollievo della Sofferenza was born of the visionary mind of a poor friar, one of the most important, recent and internationally recognized and prayed Saints, Saint Pio of Pietrelcina, right after the II World War, in a poor corner of the Southern Italy of those times. 
CSS, by its Statutes, is a not-for-profit organization. All the good work that has been done until now for the sick has been possible thanks to the generosity of donors and to the public and private funds that have been collected through the hard work of the Foundation’s researchers and clinicians, thus contributing importantly to the care of citizens from Southern Italy and underdeveloped countries and to the world research.

Fondazione di Religione e di Culto Casa Sollievo della Sofferenza - Opera di San Pio da Pietrelcina

Support our mission to ensure trustworthy and safe AI at Apart Research.

We are active contributors and enablers of AI safety research. Our mission is to minimize the risks posed by large-scale AI applications to society. To this end, we conduct research to develop safer AI and nurture talent for AI safety research roles. We organize international research sprints focused on safety topics and support talented researchers in transforming their work into fully published articles.

Apart Research

We make a firm commitment to education, research and social debate to support talent in order to make a positive impact on society

Support Education!
 
Esade is a global institution structured as a Business School, a Law School, and an Executive Education area. Esade is a global academic institution known for the quality of its education, its international outlook, and its focus on holistic personal development. Esade has strong ties to the business world. 

"Do Good. Do Better": This encompasses our reason to exist and our purpose. It is our pledge to bring meaningful change by focusing on innovation and social commitment. Esade's academic activity encompasses three main areas: 

- Education: ESADE applies a unique and innovative learning model based on the internalisation of values and the development of professional and executive competences. 

- Research: ESADE generates new knowledge that helps to improve the dynamics of organisations, businesses and the practice of law.

- Social Debate: ESADE is a platform where people can gather and discuss important issues with the aim of improving society.

Esade Foundation

Spritely Institute builds, researches, and standardizes networked technology which put people and communities first.


Centralized social media is harmful to society. We are building a gatekeeper-free decentralized system. Our mission is “social media done right”, to put people in control of their own identity and build the technology that would enable a shift to collaborative and intentional security models prioritizing active consent. To accomplish this, we will build a new architecture for the internet: removing the necessity of client-server architecture, replacing it with a participatory peer-centric model.

Spritely’s technology is being released as free and open source software aiming for multiple programming language implementations and eventual open standardization. All of our work, ranging from decentralized identity, peer-to-peer user agents, decentralized social networks, encrypted and portable storage, and distributed object programming infrastructure is being built to enable a gatekeeper-free path where users and content are not tied to a specific server.

Spritely Networked Communities Institute

Help preserve the Shulgin legacy and build a global community dedicated to scientific, therapeutic, and spiritual insight.

The Shulgin Foundation honors the revolutionary legacy of Ann and Sasha Shulgin while building a vibrant future for psychedelic science, healing, and community.

From an unassuming 200-square-foot lab in Lafayette, California, Sasha Shulgin created over 150 novel psychedelic compounds, including MDMA, while Ann pioneered therapeutic frameworks that continue to guide modern psychedelic therapy. Their historic Farm—a gathering place for four decades of psychedelic research and community—stands as both a monument and a living laboratory.

Today, the Foundation is preserving this irreplaceable heritage site while fostering a global community dedicated to scientific discovery, therapeutic advancement, and spiritual exploration. Through educational programs, archival preservation, and community gatherings, we are carrying forward the Shulgins' vision of responsible inquiry and compassionate care.

Your tax-deductible donation supports:

- Preserving the historic Shulgin Farm property
- Creating accessible psychedelic education
- Archiving invaluable research materials
- Building community across generations of researchers and healers

Join us in honoring the past while creating the future of psychedelic science and healing.

Shulgin Foundation

Founders Pledge is a global nonprofit empowering entrepreneurs to do the most good possible with their charitable giving. 

Maximize your philanthropic impact with Founders Pledge. We empower a global community of over 2,100 members, equipping them with everything needed to give effectively: from evidence-led research and expert advice on the world's most pressing problems to comprehensive infrastructure for seamless global grant-making, and a powerful network for collaboration. Together, we've already channeled over $1.5 billion to high-impact causes globally, tackling critical issues like climate change, global health, and emerging existential risks. 

When you donate through every.org today, you're joining this proven movement, and our unique funding model ensures 100% of your contribution goes directly to charity, as our operational costs are generously covered by a dedicated community of philanthropists.

Donate this Giving Season and we'll match your donation up to a value of $750,000, until Dec 31.

Founders Pledge

Created in 1997, the Fondation des Ponts supports the development of the Ecole des Ponts ParisTech and its students.

Excellent research and educational innovation 
 
Created in 1997 on the initiative of 11 major French companies, as well as the association of former ENPC students (AAENPC), the Fondation des Ponts supports the development of the Ecole des Ponts ParisTech and its students. École des Ponts ParisTech, created in 1747 under the name École Royale des Ponts et Chaussées, is a higher education establishment that trains engineers to a high level of scientific, technical and general competency. 

Recognized as a public utility, the Fondation des Ponts supports the development of the École des Ponts ParisTech by financing a whole series of projects that can be grouped according to 6 major themes:  
- Support research and educational innovation. 
- Support students, promote diversity, encourage excellence. 
- Increase the School's international reach to attract excellent teachers, researchers and students.  
- Helping startups created by students 
- Allow the School to have the facilities and equipment required to support its development. 
- Promote the historical and scientific heritage of the School. 

Visit our website:  http://www.fondationdesponts.fr/

Fondation de l'École nationale des ponts et chaussées 

Phare Bio is using AI/deep learning to discover novel classes of antibiotics to address a looming crisis in antibiotic resistance.

Phare Bio is an ambitious social venture using novel AI and deep learning approaches to antimicrobial development in collaboration with Professor Jim Collins at MIT, a founder of the field of synthetic biology. Phare is a recipient of the Audacious Project, a collaborative funding initiative between TED and other non-profits to unlock social impact on a grand scale. 

The rapid evolution of antibiotic-resistant bacteria and a dwindling discovery pipeline have resulted in an antimicrobial resistance (AMR) crisis. Today, according to the Centers for Disease Control and Prevention, someone in the U.S. acquires a resistant infection every 11 seconds; every 15 minutes someone dies as a result of one. Covid-19 has only highlighted the urgency with approximately 15% of hospitalized patients suffering from bacterial co-infections. There is a critical need for new antibiotics, and yet, pharmaceutical and biotechnology companies have largely abandoned the space in favor of more lucrative markets. 

Phare Bio launched in 2020 to tackle this critical unmet need with the latest advances in machine learning to develop entirely novel antibiotics. Integrating world-class expertise and decades of experience in artificial intelligence (AI), bioengineering, and life sciences, Phare is targeting the world's most deadly pathogens, such as Acinetobacter and Pseudomonas, with the goal of developing seven novel classes of antibiotics in seven years. 

Phare Bio

Terra Praxis designs and implements strategies that leverage science, technology and energy innovation for a prosperous planet

We co-founded TerraPraxis to design and implement strategies that leverage science, technology and energy innovation for a prosperous planet. Our mission is to innovate and accelerate scalable, equitable solutions for unsolved areas of the climate challenge. 

Our special focus is on enabling high-impact rapid transitions for neglected parts of the decarbonization challenge. 

We work with an extensive global network to define, incubate and initiate scalable strategies that fulfil the twin missions of prosperity and decarbonization. 

Terra Praxis

Creative Commons (CC) stewards a universally accessible infrastructure for open knowledge, culture, and collaboration. 

Creative Commons is the global nonprofit organization behind the CC licenses and public domain tools, enabling the free and open distribution of otherwise copyrighted work. We give every person and organization in the world a simple and standardized way to grant copyright permissions for images, music, research, journal articles, educational resources, and cultural artifacts; ensure proper attribution; and allow others to copy, distribute, and make use of those works.

We've come a long way since we first got started in 2001. When Creative Commons was  founded, the internet was a budding universe with high potential, and platforms widely used today like Wikipedia and Google were only just taking off. CC’s founders were keen to ensure that, as the internet continued to grow, safeguards to knowledge, culture, and creativity were firmly in place, and the Creative Commons license suite was born.

Now more than ever, CC recognizes the urgent need for these licenses in advancing Better Sharing, key to preserving our global commons. As we look toward the next 20 years, CC seeks to fearlessly advocate for Open Knowledge to address the many challenges our global community faces today from the Climate Crisis and educational inequalities to the spread of "fake news" and barriers in access to cultural heritage.

Creative Commons

148788709

1578280819

1873740264

2052641908

2088874155

We are a nonprofit, so we rely on the generosity of donors like you.

Choose a donation for Every.org

2109878826

2310049938

2551237796

2576076625

2594001433

283252266

2883383521

3026174861

316638097

3170054231

338811242

3705164611

3842241318

3934974605

4167807122

4287068530

440668958

1287028958

2729980760

2939442496

3440869557

671754822

87081813

1014384873

1112422858

153399038

2028390811

220342792

2266630408

2519810400

2539558839

2826465835

2843798242

2898624300

3259439560

339774024

3642494300

3902459442

4250940449

472232120

585491400

641510716

91682487

Artist, Herbalist, Breathwork Facilitator and Student of Life. www.daniellecaners.com 

founder @ camp.org, expa.com, uber.com & mix.com

.css-1wjgqn{display:inline-block;--textSize:1.5rem;--lineHeight:1.7999999999999998rem;line-height:var(--lineHeight);font-size:var(--textSize);width:100%;}Research

AHADI Foundation

The Sweat For Breath Foundation

Mersal Foundation for Charity and Development

Cuddles Foundation

Fungi Foundation

The Sweat For Breath Foundation

Research